BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.63B |
| 2 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$337M |
| 3 |
iShares China Large-Cap ETF
FXI
|
+$172M |
| 4 |
PPG Industries
PPG
|
+$132M |
| 5 |
AGN
Allergan plc
AGN
|
+$122M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Canadian National Railway
CNI
|
+$750M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$525M |
| 3 |
Apple
AAPL
|
+$317M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$275M |
| 5 |
McDonald's
MCD
|
+$167M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.55% |
| 2 | Financials | 8.18% |
| 3 | Healthcare | 5.72% |
| 4 | Consumer Discretionary | 5.19% |
| 5 | Communication Services | 4.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3026
Tandem Diabetes Care
TNDM
$1.61B
| $35.1K | ﹤0.01% |
399
+252
| +171% | +$29.3K |
|
|
CTRL
3027
DELISTED
Control4 Corporation
CTRL
| $35.1K | ﹤0.01% |
4,306
-568
| -12% | -$4.66K |
|
|
GOGL
3028
DELISTED
Golden Ocean Group
GOGL
| $35.1K | ﹤0.01% |
+2,850
| New | +$48.8K |
|
|
POZN
3029
DELISTED
POZEN INC
POZN
| $35K | ﹤0.01% |
5,994
+3,583
| +149% | +$35.1K |
|
3030
Veeva Systems
VEEV
$41B
| $35K | ﹤0.01% |
1,495
-996
| -40% | -$26K |
|
3031
Alico
ALCO
$304M
| $34.9K | ﹤0.01% |
861
+541
| +169% | +$23.5K |
|
|
CLMS
3032
DELISTED
Calamos Asset Management, Inc.
CLMS
| $34.9K | ﹤0.01% |
3,685
+2,203
| +149% | +$24.5K |
|
3033
Capital City Bank Group
CCBG
$898M
| $34.7K | ﹤0.01% |
2,323
+1,428
| +160% | +$21.6K |
|
|
AVHI
3034
DELISTED
A V Homes, Inc.
AVHI
| $34.6K | ﹤0.01% |
2,561
+1,531
| +149% | +$21.5K |
|
|
CNBKA
3035
DELISTED
Century Bancorp Inc/Mass
CNBKA
| $34.6K | ﹤0.01% |
849
+560
| +194% | +$22.9K |
|
|
ADMS
3036
DELISTED
Adamas Pharmaceuticals
ADMS
| $34.5K | ﹤0.01% |
2,061
+1,196
| +138% | +$27.2K |
|
3037
TechTarget
TTGT
$277M
| $34.5K | ﹤0.01% |
4,048
+2,419
| +148% | +$22.2K |
|
|
SNAK
3038
DELISTED
Inventure Foods, Inc.
SNAK
| $34.4K | ﹤0.01% |
3,879
+2,252
| +138% | +$20.9K |
|
|
USAK
3039
DELISTED
USA Truck Inc
USAK
| $34.4K | ﹤0.01% |
1,999
+1,183
| +145% | +$23.6K |
|
|
KCLI
3040
DELISTED
KANSAS CITY LIFE INS CO NEW (MO)
KCLI
| $34.4K | ﹤0.01% |
732
+425
| +138% | +$19.7K |
|
|
GNRT
3041
DELISTED
Gener8 Maritime, Inc.
GNRT
| $34.3K | ﹤0.01% |
+3,134
| New | +$40.9K |
|
|
MBVT
3042
DELISTED
Merchants Bancshares Inc
MBVT
| $34.3K | ﹤0.01% |
1,166
+752
| +182% | +$22.7K |
|
|
TSYS
3043
DELISTED
TELECOMMUNICATIONS SYS INC "A"
TSYS
| $34.3K | ﹤0.01% |
9,960
+5,782
| +138% | +$20.6K |
|
|
VTAE
3044
DELISTED
VITAE PHARMACEUTICALS INC COMMON STOCK
VTAE
| $34.1K | ﹤0.01% |
3,098
+1,994
| +181% | +$21.2K |
|
3045
SITE Centers
SITC
$158M
| $34.1K | ﹤0.01% |
1,718
-32,894
| -95% | -$670K |
|
3046
Hurco Companies Inc
HURC
$143M
| $34K | ﹤0.01% |
1,297
+753
| +138% | +$23.2K |
|
3047
MGP Ingredients
MGPI
$389M
| $34K | ﹤0.01% |
2,121
+1,231
| +138% | +$19.3K |
|
|
SIOX
3048
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| $33.9K | ﹤0.01% |
+328
| New | +$38.5K |
|
3049
Agilysys
AGYS
$3.25B
| $33.8K | ﹤0.01% |
3,042
+1,766
| +138% | +$17.3K |
|
|
HZN
3050
DELISTED
Horizon Global Corporation
HZN
| $33.8K | ﹤0.01% |
+3,831
| New | +$42.8K |
|
Similar funds
BNP Paribas Financial Markets's Q3 2015 Portfolio in Review
As of Q3 2015, BNP Paribas Financial Markets held 3,791 positions worth $39.9B, up 11% from $35.8B the previous quarter. Its ten largest holdings account for 45% of the portfolio.
BNP Paribas Financial Markets deployed $7.43B of net new capital in Q3 2015, opening 248 new positions and adding to 2,429 existing holdings. Its largest new stake was Allergan plc: 397,434 shares worth $108M.
By sector, the portfolio is most concentrated in Technology at 8.6% of assets, down from 10% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $525M trimmed.
- BNP Paribas Financial Markets's largest Q3 2015 buy was Allergan plc: 397,434 shares worth $108M.
- BNP Paribas Financial Markets added most to State Street SPDR S&P 500 ETF Trust in Q3 2015, an estimated $5.63B increase.
- BNP Paribas Financial Markets's biggest Q3 2015 reduction was iShares Russell 2000 ETF, cutting an estimated $525M.
- BNP Paribas Financial Markets fully exited Canadian National Railway in Q3 2015, selling an estimated $750M.
- BNP Paribas Financial Markets's ten largest holdings make up 45% of its $39.9B portfolio in Q3 2015.
- BNP Paribas Financial Markets opened 248 new positions and closed 172 in Q3 2015.
- BNP Paribas Financial Markets's portfolio value rose 11% quarter-over-quarter to $39.9B.
Based on BNP Paribas Financial Markets's 13F filing for Q3 2015, filed 13 Nov 2015.